One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful ...
SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT ®-HD2 study demonstrating an established long-term safety ...
Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...
You might have read and heard a lot of neurological conditions like Alzheimer’s and Parkinson’s, however, there’s another similar yet rarer disease that affects your body movement and thinking ability ...
Hosted on MSN
uniQure Stock Rises Pre-Market After Investigational Huntington’s Disease Drug Slows Disease In Trial
uniQure N.V. (QURE) on Wednesday said that a high dose of its experimental drug AMT-130 demonstrated a statistically significant slowing of disease progression in Huntington’s disease in an ...
The death of Phebe Hedges -- The social course of St. Vitus's dance -- Inventing hereditary chorea -- Chorea and the clinical gaze -- The eyes of Elizabeth B. Muncey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback